In addition, we found that lipolysis and β-oxidation are also enhanced in brain as shown by increased neuronal mRNA expression of pparγ and of its target gene abca1. Since activation of PPARγ reduces AD-pathology and improves cognitive function in mouse models of AD [38] this current finding might also contribute to neuroprotection. The gene discussed is ABCA1; the disease is Alzheimer disease.